Summary:
This study is being conducted to see if the investigational drug might improve the activities of daily living in patients with hallucinations and delusions associated with Parkinson's disease psychosis.
Qualified Participants Must:
• be 40 years of age or older with Parkinson's disease
•
have one or both of these symptoms: delusions (false or mistaken beliefs), hallucinations (seeing or hearing things that are not really there)
•
have a relative, housemate, or friend assist during the study and attend clinic visits
Qualified Participants May Receive:
The investigational drug
Compensation for time and travel may be available